Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021;13(1):38-48.
doi: 10.1159/000509714. Epub 2020 Dec 3.

Downregulation of miRNA-451a Promotes the Differentiation of CD4+ T Cells towards Th2 Cells by Upregulating ETS1 in Childhood Asthma

Affiliations

Downregulation of miRNA-451a Promotes the Differentiation of CD4+ T Cells towards Th2 Cells by Upregulating ETS1 in Childhood Asthma

Tianyue Wang et al. J Innate Immun. 2021.

Abstract

Children exposed to common aeroallergens may develop asthma that progresses into adulthood. Inflammation regulated by T helper 2 (Th2) cells, a specific subpopulation of CD4+ T lymphocytes, is involved in asthmatic injury. Herein, our microarray data indicated that microRNA-451a-5p (miRNA-451a) expression decreased by 4.6-fold and ETS proto-oncogene 1 (ETS1) increased by 2.2-fold in the peripheral blood lymphocytes isolated from asthmatic children (n = 4) as compared to control individuals (n = 4). The negative correlation between miRNA-451a and ETS1 was further validated in 40 CD4+ T cell samples (10 healthy vs. 30 asthmatic samples). In vitro, naïve CD4+ T cells isolated from control individuals were cultured under Th2 cell polarizing condition. miRNA-451a expression decreased while ETS1 increased in CD4+ T cells in the setting of Th2 cell polarization. Moreover, miRNA-451a knockdown enhanced Th2 cell polarization - cells positive for both GATA3 (GATA binding protein 3, a Th2-transcription factor) and CD4 increased, and the generation of Th2 cell cytokines, interleukin (IL)5 and IL13, increased. In contrast, miRNA-451a overexpression inhibited Th2 cell differentiation. Interestingly, dual-Luciferase assay proved ETS1 as a novel target of miRNA-451a. Moreover, enforced expression of ETS1 partially restored miRNA-451a-induced inhibition of IL5 and IL13, and increased the GATA3+CD4+ cell population. Collectively, our work demonstrates that downregulation of miRNA-451a upregulates ETS1 expression in CD4+ T cells, which may contribute to Th2 cell differentiation in pediatric asthma.

Keywords: Childhood asthma; ETS proto-oncogene 1; Th2 cell differentiation; Type 2 inflammation; miRNA-451a.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Downregulation of miRNA-451a and upregulation of ETS1 observed in lymphocytes derived from children with asthma (CA). a, c Volcano blots showed downregulated miRNAs as blue dots, and upregulated miRNAs as red dots. b, d All differentially expressed miRNAs and mRNAs are shown in heatmaps. Each row represents an miRNA or an mRNA, and each column indicates a sample. e The predictive targets of miR-451a with expression levels negatively correlated with miR-451a based on microarray data are shown in the Venn diagram. f The expression correlation between miR-451a and ETS1 CD4+ T cell samples from 10 control and 30 asthmatic children was analyzed with the Spearman correlation test (p < 0.05).
Fig. 2
Fig. 2
Downregulation of miRNA-451a and upregulation of ETS1 are observed during the differentiation of CD4+ T cells towards Th2 cells. a Representative images of flow cytometry analysis showing GATA3+CD4+ cells. b qRT-PCR analysis of IL5 and IL13 in naïve CD4+ T cells under Th2 polarizing conditions. c The level of miRNA-451a and ETS1 was analyzed by qRT-PCR or Western blot. Statistically significant differences in b and c were analyzed by two-tailed unpaired t test (n = 3). ** p < 0.01, *** p < 0.001.
Fig. 3
Fig. 3
miRNA-451a suppresses the differentiation of CD4+ T cells towards Th2 cells. a, c Representative images of flow cytometry analysis showing GATA3+CD4+ cells. b, d The protein levels of IL5 and IL13 in CD4+ T cells detected by Western blot. e, f ELISA analysis showed the level of IL5 and IL13 after silencing or overexpression of miRNA-451a. Data were analyzed by two-tailed unpaired t test or one-way ANOVA followed by Tukey's multiple comparation (n = 3). ** p < 0.01, *** p < 0.001. ns indicates a p value >0.05.
Fig. 4
Fig. 4
miRNA-451a directly targets ETS1 in CD4+ T cells in vitro. a, c Miranda (http://www.microrna.org/microrna/home.do) and RNAhybrid (https://bibiserv.cebitec.uni-bielefeld.de/rnahybrid) were used for target prediction. Sequence information of ETS1 WT and mutant-type (MT) 3′UTR. These fragments were inserted into pmirGLO plasmids, and co-transfected into 293T cells together with miRNA-451a mimics or NC mimics. b, d The relative luciferase activity was determined and analyzed with one-way ANOVA. Additionally, CD4+ T cells were induced with Th2 cell differentiation followed by infection with LV-anti-miRNA-451a and LV-miRNA-451a. The expression levels of ETS1 were analyzed by Western blot (e) and real-time qPCR (f). Data in e and f are shown as the mean ± SD from three separate experiments, with two-tailed unpaired t test (n = 3). ** p < 0.01, *** p < 0.001. NC, negative control.
Fig. 5
Fig. 5
miRNA-451a inhibits Th2 cell differentiation through downregulating ETS1. Cells overexpressing miRNA-451a were infected with LV-OE-ETS1 or LV-OE-NC. a Representative images of flow cytometry analysis showing GATA3+CD4+ cells. b The mRNA levels of IL5 and IL13 were analyzed by qRT-PCR. c The protein expression of ETS1, IL5, and IL13 were determined with Western blot. d ELISA analysis of IL5 and IL13. The quantitative analyses in b and c are presented as the mean ± SD calculated based on three separate experiments with two-tailed unpaired t tests (n = 3). ** p < 0.01, *** p < 0.001. NC, negative control; OE, overexpression.

References

    1. Fahy JV. Type 2 inflammation in asthma—present in most, absent in many. Nat Rev Immunol. 2015 Jan;15((1)):57–65. - PMC - PubMed
    1. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008 Sep;372((9643)):1107–19. - PubMed
    1. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012 May;18((5)):716–25. - PubMed
    1. Locksley RM. Asthma and allergic inflammation. Cell. 2010 Mar;140((6)):777–83. - PMC - PubMed
    1. Holgate ST. Innate and adaptive immune responses in asthma. Nat Med. 2012 May;18((5)):673–83. - PubMed

LinkOut - more resources